PL3010962T5 - Wytwarzanie mikrocząstek polilaktydowo-poliglikolidowych mających esowaty profil uwalniania - Google Patents

Wytwarzanie mikrocząstek polilaktydowo-poliglikolidowych mających esowaty profil uwalniania

Info

Publication number
PL3010962T5
PL3010962T5 PL14733524.4T PL14733524T PL3010962T5 PL 3010962 T5 PL3010962 T5 PL 3010962T5 PL 14733524 T PL14733524 T PL 14733524T PL 3010962 T5 PL3010962 T5 PL 3010962T5
Authority
PL
Poland
Prior art keywords
polylactide
preparation
release profile
sigmoidal release
polyglycolide microparticles
Prior art date
Application number
PL14733524.4T
Other languages
English (en)
Other versions
PL3010962T3 (pl
Inventor
Evangelos Karavas
Efthymios Koutris
Sotiria HAITIDOU
Theofanis MANTOURLIAS
Georgia PAPANIKOLAOU
Original Assignee
Pharmathen S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55532293&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3010962(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.
Priority claimed from PCT/EP2014/001652 external-priority patent/WO2014202214A1/en
Publication of PL3010962T3 publication Critical patent/PL3010962T3/pl
Publication of PL3010962T5 publication Critical patent/PL3010962T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/14—Powdering or granulating by precipitation from solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/16—Biodegradable polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14733524.4T 2013-06-20 2014-06-18 Wytwarzanie mikrocząstek polilaktydowo-poliglikolidowych mających esowaty profil uwalniania PL3010962T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2013001821 2013-06-20
EP14733524.4A EP3010962B2 (en) 2013-06-20 2014-06-18 Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile
PCT/EP2014/001652 WO2014202214A1 (en) 2013-06-20 2014-06-18 Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile

Publications (2)

Publication Number Publication Date
PL3010962T3 PL3010962T3 (pl) 2018-01-31
PL3010962T5 true PL3010962T5 (pl) 2023-05-15

Family

ID=55532293

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14733524.4T PL3010962T5 (pl) 2013-06-20 2014-06-18 Wytwarzanie mikrocząstek polilaktydowo-poliglikolidowych mających esowaty profil uwalniania

Country Status (6)

Country Link
EP (1) EP3010962B2 (pl)
CY (1) CY1119397T1 (pl)
HR (1) HRP20171402T4 (pl)
PL (1) PL3010962T5 (pl)
RS (1) RS56427B2 (pl)
SI (1) SI3010962T2 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792477A (en) † 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US6194006B1 (en) 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US6331317B1 (en) † 1999-11-12 2001-12-18 Alkermes Controlled Therapeutics Ii Inc. Apparatus and method for preparing microparticles
US6264987B1 (en) † 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight

Also Published As

Publication number Publication date
HRP20171402T1 (hr) 2017-11-03
EP3010962B2 (en) 2023-02-08
CY1119397T1 (el) 2018-02-14
SI3010962T2 (sl) 2023-04-28
RS56427B1 (sr) 2018-01-31
SI3010962T1 (sl) 2017-10-30
PL3010962T3 (pl) 2018-01-31
EP3010962B1 (en) 2017-07-26
RS56427B2 (sr) 2023-04-28
HRP20171402T4 (hr) 2023-07-21
EP3010962A1 (en) 2016-04-27

Similar Documents

Publication Publication Date Title
ZA201509354B (en) Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile
AU354897S (en) Hook
SG10202102787WA (en) Respiratory interface
SG11201507824QA (en) Free handrail
ZA201508642B (en) Malaria vaccine
EP3039203A4 (en) STAIRWAY
GB2522301B (en) Obtaining a configuration of a network
EP2942128A4 (en) FLAKE-SHAPED MICROPARTICLES
PL3077027T3 (pl) Zacisk zabezpieczający
EP3023416A4 (en) PREPARATION OF (-) - HUPERZINE A
EP2816011A4 (en) MAGNESIUM HYDROXIDE-MICROPARTICLES
EP2960532A4 (en) HOOK
HK1211276A1 (en) Elevator
SG2014003230A (en) Escalator step
GB2514585B (en) Task scheduler
PL3066223T5 (pl) Heteropolisacharydy
AU353098S (en) A hook
HRP20171402T1 (hr) Priprava polilaktidno-poliglikolidnih mikročestica sa sigmoidnim profilom oslobađanja
GB201322790D0 (en) Walkways
GB201319717D0 (en) A shower head
HK1189327A2 (en) A type of hanging buckle
GB2511128B (en) A hanger
ZA201405720B (en) Diagnosis of malaria
AU355585S (en) A coat
GB201312595D0 (en) A safety handrail